BKM120 sensitizes C6 glioma cells to temozolomide via suppression of the PI3K/Akt/NF‑κB/MGMT signaling pathway

Li Mao(Sichuan University), Yan Liu(Chongqing Medical University)
Oncology Letters
September 22, 2017
Cited by 24


Related Papers